Tenon Medical, Inc.

TNON Healthcare Medical Devices

Tenon Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.9 million, up 20.4% from fiscal 2024. In the quarter to June 2026, revenue grew 126.8%, EPS grew 1.88% and free cash flow fell 21.8%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.

2.70 0.21 −7.22%
Market cap
$7.8M
P/E
0.0×
Fwd P/E
−0.7×
Dividend yield
—
F-score
4/9
Altman Z
−13.00
Beneish M
−1.81
Dividend safety
n/a

Tenon Medical, Inc. (TNON) EV/Sales

Alert me on EV/Sales

As of 16 October 2026, Tenon Medical, Inc. (TNON) trades at a EV/Sales of −0.1×. Over the past ten years it has ranged from −14.2× (September 2022) to 238× (May 2022); the current reading is higher than 33% of that period. That is below the Medical Devices industry median of 2.2× and below the Healthcare sector median of 3.4×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 0.9× —
FY2024 −1.2× —
FY2023 0.2× (96.33%)
FY2022 6.8× (92.99%)
FY2021 96.6× 0.00%
FY2020 96.6× 0.00%
FY2019 96.6× —

Quarterly newest first

Period EV/Sales Change
Jun 2026 0.5× (46.98%)
Mar 2026 0.9× (7.05%)
Dec 2025 0.9× (55.36%)
Sep 2025 2.1× —
18 more quarters

Against its own ten years

Low −14.2× High 238×
Ten-year median 0.2×
Current reading's percentile 33

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on TNON